Veracyte reported $47.83M in Gross Profit on Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Agenus AGEN:US $ 18.9M 6.5M
Agilent A:US $ 861M 49M
Anika Therapeutics ANIK:US $ 24.86M 3.06M
Biocept BIOC:US $ 9.61M 5.66M
Bruker BRKR:US $ 298.2M 8.1M
Exact Sciences EXAS:US $ 377.04M 25.17M
Illumina ILMN:US $ 767M 48M
Karyopharm Therapeutics KPTI:US $ 38.74M 7.5M
Laboratory Of America LH:US $ 1122.7M 110.2M
Siemens SIE:GR 5.74B 464M
Sonic Healthcare SHL:AU $ 3.95B 409.81M
Thermo Fisher Scientific TMO:US $ 4730M 734M
Veracyte VCYT:US $ 47.83M 3.76M
Waters WAT:US $ 407.11M 2.23M